Viral clearance studies are a critical component of ensuring the safety of biologics manufactured using cell-based systems, including monoclonal antibodies and recombinant proteins. As regulatory expectations continue to evolve, study designs must balance scientific rigor, risk-based decision making, and development timelines. This presentation provides practical guidance on tailoring viral clearance study design across different phases … Continued